EMILY ENTREKIN: Open Payments
NPI 1528534922 · GARDENDALE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,500 in 107 payments from 19 companies in 2025. Trend: 2023 $446 · 2024 $670 · 2025 $1,500
Food & beverage: $1,500
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $371 |
| Novo Nordisk Inc | 22 | $262 |
| Lilly USA, LLC | 12 | $180 |
| Amgen Inc. | 10 | $135 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $76 |
| SHIELD THERAPEUTICS INC | 4 | $71 |
| Exact Sciences Corporation | 4 | $67 |
| Corcept Therapeutics | 3 | $56 |
| SANOFI-AVENTIS U.S. LLC | 3 | $44 |
| Siemens Medical Solutions USA, Inc. | 1 | $41 |
Products named: MOUNJARO, Wegovy, UBRELVY, VRAYLAR, TRINTELLIX, EVENITY, ACCRUFER, QULIPTA.
Industry payments across AL — which companies pay providers there.
